Status:

COMPLETED

Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients

Lead Sponsor:

Policlinico Hospital

Conditions:

Fungal Prophylaxis

Candida Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Purpose. Oral chemoprophylaxis has been advocated to reduce the incidence of Candida colonization and infection. However, Candida prophylaxis in intensive care unit (ICU) is still a matter of debate. ...

Detailed Description

Multiple-site testing for fungi included: tracheal secretions, pharingael swab, stomach contents, rectal swab, groin skin fold swab, urine, and blood. These tests will be performed in each patient at ...

Eligibility Criteria

Inclusion

  • surgical patients admitted to our ICU older than 18 years of age and expected to require invasive mechanical ventilation for more than 48 h.

Exclusion

  • pregnancy,
  • proven Candida infection,
  • prophylactic or curative antifungal treatment within the last 2 months,
  • contraindication to oral drug administration,
  • known allergy to nystatin or its derivatives, and prior inclusion in the study

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2010

Estimated Enrollment :

99 Patients enrolled

Trial Details

Trial ID

NCT01495039

Start Date

November 1 2008

End Date

February 1 2010

Last Update

April 5 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Intensive care Unit, Policlinico Hospital Bari

Bari, Italy, Italy, 70100